Literature DB >> 22654272

Hepatic radioembolization complicated by fulminant hepatic failure.

Nabeel Hamoui1, Robert K Ryu.   

Abstract

A 68-year-old man with a history of metastatic colorectal carcinoma underwent left hepatic lobectomy and right hepatic wedge resection as initial treatment of his metastatic disease. He subsequently underwent right lobar radioembolization for treatment of a segment 8 lesion. At 6 weeks postembolization, he developed hepatic dysfunction which rapidly progressed to fulminant liver failure. A liver biopsy revealed hepatic venous obstruction and fibrosis. The patient died 14 weeks after radioembolization.

Entities:  

Keywords:  Hepatic failure; colorectal carcinoma; fibrosis; liver failure; metastatic disease; radiation induced liver disease; radioembolization; transarterial embolization; yttrium-90

Year:  2011        PMID: 22654272      PMCID: PMC3193342          DOI: 10.1055/s-0031-1280674

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  14 in total

1.  Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.

Authors:  James E Goin; Riad Salem; Brian I Carr; Janet E Dancey; Michael C Soulen; Jean-Francois H Geschwind; Kathleen Goin; Mark Van Buskirk; Kenneth Thurston
Journal:  J Vasc Interv Radiol       Date:  2005-02       Impact factor: 3.464

2.  Radiation-induced liver disease.

Authors:  Radwan F Khozouz; Syed Z Huq; Michael C Perry
Journal:  J Clin Oncol       Date:  2008-09-08       Impact factor: 44.544

3.  Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial.

Authors:  Bernard Nordlinger; Philippe Rougier; Jean-Pierre Arnaud; Muriel Debois; Jaques Wils; Jean-Claude Ollier; Olivier Grobost; Philippe Lasser; Jacob Wals; Jerome Lacourt; Jean-François Seitz; Jose Guimares dos Santos; Harry Bleiberg; Rémy Mackiewickz; Thierry Conroy; Olivier Bouché; Thierry Morin; Liliana Baila; Eric van Cutsem; Laurent Bedenne
Journal:  Lancet Oncol       Date:  2005-07       Impact factor: 41.316

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

5.  Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients.

Authors:  L Solbiati; T Livraghi; S N Goldberg; T Ierace; F Meloni; M Dellanoce; L Cova; E F Halpern; G S Gazelle
Journal:  Radiology       Date:  2001-10       Impact factor: 11.105

6.  Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

Authors:  Kent T Sato; Robert J Lewandowski; Mary F Mulcahy; Bassel Atassi; Robert K Ryu; Vanessa L Gates; Albert A Nemcek; Omar Barakat; Al Benson; Robert Mandal; Mark Talamonti; Ching-Yee O Wong; Frank H Miller; Steven B Newman; John M Shaw; Kenneth G Thurston; Reed A Omary; Riad Salem
Journal:  Radiology       Date:  2008-03-18       Impact factor: 11.105

7.  Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.

Authors:  Mary F Mulcahy; Robert J Lewandowski; Saad M Ibrahim; Kent T Sato; Robert K Ryu; Bassel Atassi; Steven Newman; Mark Talamonti; Reed A Omary; Al Benson; Riad Salem
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

Review 8.  Mediastinal venous anomalies: potential pitfalls in cancer diagnosis.

Authors:  A R Padhani; H L Hale
Journal:  Br J Radiol       Date:  1998-07       Impact factor: 3.039

9.  Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.

Authors:  Andrew S Kennedy; Patrick McNeillie; William A Dezarn; Charles Nutting; Bruno Sangro; Dan Wertman; Michael Garafalo; David Liu; Douglas Coldwell; Michael Savin; Tobias Jakobs; Steven Rose; Richard Warner; Dennis Carter; Stephen Sapareto; Subir Nag; Seza Gulec; Allison Calkins; Vanessa L Gates; Riad Salem
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-01-20       Impact factor: 7.038

10.  Liver disease induced by radioembolization of liver tumors: description and possible risk factors.

Authors:  Bruno Sangro; Belen Gil-Alzugaray; Javier Rodriguez; Iosu Sola; Antonio Martinez-Cuesta; Antonio Viudez; Ana Chopitea; Mercedes Iñarrairaegui; Javier Arbizu; Jose I Bilbao
Journal:  Cancer       Date:  2008-04-01       Impact factor: 6.860

View more
  4 in total

1.  [Selective internal radioembolization in nonresectable hepatocellular carcinoma].

Authors:  A Bauschke; A Altendorf-Hofmann; M Freesmeyer; T Winkens; C Malessa; J-H Schierz; U Teichgraeber; U Settmacher
Journal:  Chirurg       Date:  2016-11       Impact factor: 0.955

Review 2.  Side effects of yttrium-90 radioembolization.

Authors:  Ahsun Riaz; Rafia Awais; Riad Salem
Journal:  Front Oncol       Date:  2014-07-29       Impact factor: 6.244

Review 3.  Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know.

Authors:  Ijin Joo; Hyo-Cheol Kim; Gyoung Min Kim; Jin Chul Paeng
Journal:  Korean J Radiol       Date:  2018-02-22       Impact factor: 3.500

4.  Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First in vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with 188Re.

Authors:  José Carlos De La Vega; Pedro Luis Esquinas; Cristina Rodríguez-Rodríguez; Mehrdad Bokharaei; Igor Moskalev; David Liu; Katayoun Saatchi; Urs O Häfeli
Journal:  Theranostics       Date:  2019-01-25       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.